Compare WKHS & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WKHS | CCM |
|---|---|---|
| Founded | 2007 | 1997 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Medical/Nursing Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4M | 14.9M |
| IPO Year | 2008 | 2009 |
| Metric | WKHS | CCM |
|---|---|---|
| Price | $2.58 | $3.91 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $21.00 | N/A |
| AVG Volume (30 Days) | ★ 76.8K | 839.0 |
| Earning Date | 05-14-2026 | 04-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 86.92 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $763,173.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.53 | $3.18 |
| 52 Week High | $11.80 | $10.77 |
| Indicator | WKHS | CCM |
|---|---|---|
| Relative Strength Index (RSI) | 30.20 | 54.16 |
| Support Level | $0.92 | $3.58 |
| Resistance Level | $3.60 | $4.12 |
| Average True Range (ATR) | 0.22 | 0.11 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 10.34 | 55.32 |
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.